August 1, 2017 : DCMS #356

DISASTERS AVERTED — Near Miss Case Studies

Sam Brand Gets Ready for the Tour of Utah

EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners

Dr. Karl Nadolsky Part 3, Nutrition and Physical Activity

HOMERUN SLIDES — Great Clinical Presentation Highlights

A Unifying Pathophysiologic Approach to The Complications of Diabetes in the Context of the Beta-cell Classification of Diabetes Part 5

CLINICAL GEMS — The Best from Diabetes Texts

International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #84: Measuring Insulin Action In Vivo

MOST POPULAR ARTICLES OF THE MONTH

#1 Type 1 Cured in Mice
#2 Metformin and Aging
#3 Novel Antihypertensive Lowers HbA1c in People with Diabetes

This week we have part 3 of our Exclusive Interview from the AACE meeting in Austin. Dr. Karl Nadolsky talks about the value of managing exercise and diet for diabetes care. There is a direct correlation between control and athletic success in patients with diabetes. So this week in Disasters Averted, on the first day of the Tour of Utah, we share information from one of the Team NovoNordisk riders and how he uses food choices to be the best athlete in one of the hardest sports.

Dave Joffe

Editor-in-chief

Team Novo Nordisk’s Sam Brand is making his men’s professional team debut at this year’s Tour of Utah. The Isle of Man native has been called up to race as a stagiaire, which stands for intern in cycling lingo, for the remainder of the 2017 season with the ultimate goal of earning a pro contract for next year.

In part 3 of this Exclusive Interview, Dr. Karl Nadolsky talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas. Dr. Nadolsky compares the importance of fitness and diet in the management of diabetes.

In this week’s Homerun Slides, the former principles of diabetes complications.

The glucose clamp: Rather than using exogenous agents that suppress beta-cell insulin secretion, the glucose clamp uses external feedback control to “open the loop” between insulin secretion and sensitivity. The glucose clamp is a powerful and widely used method to attain a quantitative measure of insulin sensitivity, and has been applied in many hundreds of experimental studies.

Ralph DeFronzo and his researchers at UT Health at San Antonio announced that they have cured type 1 diabetes.

Study shows age-related comorbidities decreased in males over 65 who take metformin.

Combination ANRI sacubitril/valsartan (EntrestoR) showed significant reduction in risk for cardiovascular death and hospitalization for worsening heart failure.